Machelle Sanders
Director at Biocryst Pharmaceuticals Inc (BCRX); Director at Fortrea Holdings Inc. (FTRE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $243K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 5SEC | FTREFortrea Holdings Inc. | Sell | 9,70036,399 held (−21%) | $18.01 | $175K | +24.9% |
| Nov 17SEC | BCRXBiocryst Pharmaceuticals Inc | Sell Plan | 9,60030,642 held (−24%) | $7.14 | $69K | +9.1% |
- Sell
Director Machelle Sanders sold $69K of BCRX at $7.14 — pre-scheduled 10b5-1 plan sale.